General Discussion

Biden's order directed the Department of Health and Human Services to explore strategies to reduce costs. The U.S. Centers for Medicare & Medicaid Services (CMS) responded to the order with programs to cap the price of certain generic drugs at $2 for Medicare beneficiaries, improve Medicaid access to high-cost cell and gene therapies and to streamline the evidence-gathering process for new drugs.

How much harm this will result in is hard for me to assess at this point.

But cruelty is the point, it's what the MAGAts love.